Format
Comparisons
Side-by-side looks at how two options actually differ.
39 articles
Stress and recoveryBurnout isn't depression — and that's why antidepressants don't helpIf you've been told you're depressed but the medication isn't reaching whatever this is, there's a reasonable chance the diagnosis is incomplete. What gets clinically labeled as "treatment-resistant depression" in high-functioning, chronically overloaded people is often a separate physiological state with its own mechanism — and the standard depression playbook doesn't address it.8 min readAthletic recoveryOvertraining vs. training stress — why athletes plateauThe numbers are going the wrong way. Paces that used to feel moderate now feel hard. Lifts that were grinding upward have stalled and started drifting down. Heart rate is elevated for the same effort. Sleep is worse, mood is worse, recovery is worse, and the obvious move — train more, push through — is making everything more obvious. This is the territory where serious athletes start to suspect they are losing fitness, when in fact they are losing their capacity to absorb the work they are already doing.7 min readCompounding and compliance503A vs 503B: what "compounded" actually meansYou're looking at two pharmacy websites side by side and they both have peptides for sale. One mentions 503A. The other mentions 503B. You don't know what either of those numbers means, and you don't want to be the kind of person who asks. So you squint at the fine print, look for a trust badge or a seal, and eventually just pick the one with the cleaner website.8 min readSleep and recoveryAnxiety and sleep peptides compared — Selank, DSIP, oxytocin, low-dose SermorelinYou don't fall asleep so much as lie there cataloguing. The ceiling, the ambient hum of whatever your brain decided is unresolved, the fact that you know you need to sleep and that knowledge is precisely what's making it harder. You wake at 3 a.m. for no external reason and then spend an hour not-quite-conscious, not-quite-asleep, circling. The next day arrives already thinned out and the anxiety that kept you up is worse for the sleep debt, and the sleep debt is worse for the anxiety. The loop has its own particular logic and it's immune to basic advice.9 min readMetabolic healthAOD-9604 vs Frag 176-191 — same fragment, different framingsIf you've spent any time in peptide research forums or browsed compounding pharmacies that deal in GH-related compounds, you've likely seen both names: AOD-9604 and Fragment 176-191, sometimes written hGH Frag 176-191 or just Frag 176-191. They appear in different contexts, carry different connotations, and are priced and marketed differently. They are, for almost all practical purposes, the same molecule — with a caveat worth understanding precisely.7 min readGrowth hormone and recoveryDAC vs no DAC — what the half-life difference means in practiceYou've done enough reading to know there are two versions. CJC-1295 with DAC and CJC-1295 without DAC — also called Mod GRF 1-29, also called Modified GRF 1-29, also found in enough abbreviations and vendor names that the nomenclature itself starts to feel like a test. You've probably seen protocols recommending one and protocols recommending the other, sometimes with confidence that feels disproportionate to the evidence available. The distinction between them is real and pharmacologically significant. But it's a trade-off, not a verdict.7 min readAnti-aging and cellular healthN-Acetyl Epithalon Amidate vs Epitalon — why the modification mattersYou've looked into Epitalon. You've read about Khavinson's research, the telomerase hypothesis, the Russian clinical tradition. And then, browsing sources and supplier listings, you encounter a different name: N-Acetyl Epithalon Amidate. Or Epithalon Amidate. Or Acetyl Epitalon. The naming is inconsistent in the way that peptide supplement markets tend to be. What isn't inconsistent is the underlying question: is this the same compound, a better version, or something different enough to matter?7 min readGrowth hormone and recoveryFollistatin vs myostatin antibodies — different strategies, similar limitsThe field had a target it was confident in and a question it thought it knew how to answer. Myostatin suppresses muscle growth. Block myostatin, build muscle. The biology said yes. The mouse data said yes, emphatically and reproducibly. The Belgian Blue cattle had been demonstrating yes in Belgian fields for a hundred and fifty years without anyone asking for a peer review. What remained was engineering — picking the right pharmacological strategy for blocking a signaling protein in a human being, running the trials, publishing the results. Straightforward science.7 min readHormonal and endocrineGH peptides vs TRT — picking the right intervention for the right deficit (men)You don't feel the way you used to feel, and you've been patient about it. Not dramatically worse — nothing that sends you to urgent care — but the baseline has shifted. Recovery takes longer. Sleep isn't as restorative as it should be. The body you used to maintain with modest effort now requires more and returns less. Libido has quieted in a way that feels like more than circumstance. Your energy through the afternoon has become something you manage rather than something you have. You've read enough to know that two categories of intervention keep appearing in the conversation: testosterone replacement therapy and growth hormone peptides. You want to understand which one — if either — addresses what you're actually dealing with.10 min readCompounding and complianceGray market vs compounding pharmacy — the supply chain distinction that matters mostAnyone who has spent time evaluating peptide options has arrived at the same question eventually, even if they didn't frame it this way: where is this actually coming from, and what does that mean? Two websites side by side, similar compound names, similar descriptions of mechanisms and expected effects, sometimes similar visual design. One costs substantially more and requires a prescription and a clinical consultation. One costs less, ships immediately, no prescription required. The price and convenience comparison is obvious. The supply chain comparison — the question of what these two purchase paths actually represent in terms of quality, legality, and accountability — is not stated anywhere on either site in a way that makes it easy to evaluate.4 min readHormonal and endocrineHCG vs gonadorelin vs enclomiphene — the TRT-adjunct decision treeYour prescribing provider has explained that starting testosterone replacement will suppress your body's own hormonal axis. Your LH will drop toward zero. Your testes will stop producing their own testosterone. Spermatogenesis will slow. And if you want to preserve any of that — fertility, testicular volume, the option of coming off someday — you'll need to do something alongside the testosterone, not just instead of it. Then they hand you a choice that nobody warned you would exist. Three options. Different mechanisms. Different drawbacks. The provider lays them out and you realize you're making a pharmacological decision without quite enough information to make it well.5 min readGrowth hormone and recoveryIGF-1 LR3 vs IGF-1 DES — the localization questionYou've read enough about IGF-1 to understand the appeal. You also understand that the compound sitting in a vial has to actually reach the tissue you care about, and that the pharmacology of getting a peptide from an injection site to a receptor is more complicated than it sounds. The engineer in you wants to know: is there a version of this that goes where you point it?7 min readHormonal and endocrineMelanotan I vs Melanotan II — what the differences actually areYou've seen the names used interchangeably in forums, in vendor listings, sometimes even in news articles. Melanotan. MT-1. MT-2. Melanotan I. Melanotan II. They're treated as versions of the same thing — different doses of the same basic compound, maybe, or sequential iterations with minor tweaks. They are not. The differences between Melanotan I and Melanotan II are mechanistically significant, practically important, and directly relevant to anyone trying to understand why one of these compounds is a regulated pharmaceutical with an approved clinical application and the other is not approved anywhere in the world for human use. They are related peptides that share a partial origin story and diverge sharply from there.7 min readMetabolic healthMicrodose vs full-dose GLP-1 — picking the right intensity for the right goalYou've done the reading. You know GLP-1 receptor agonists exist. You know they work. But the conversation around them — the before-and-afters, the celebrity speculation, the prescribing provider ads — all seems to point at one thing: the full dose, the dramatic weight loss, the transformation narrative. And that's not quite what you're looking for. Or maybe it is, and you're not sure. You're trying to figure out whether the intensity of the intervention matches the intensity of your situation, and nobody has given you a framework for that.7 min readMitochondrial healthNAD+ vs MOTS-c vs SS-31 vs Humanin — the mitochondrial peptide stack, decodedYou got your labs back and your biological age came out higher than your chronological age. Or the fatigue is real — not the kind that coffee fixes, not the kind that a good night's sleep fully resolves — a deeper, structural tiredness that has started to feel like a baseline rather than a symptom. Or you've been researching longevity seriously and you've arrived at the mitochondria, because the research keeps pointing there: cellular energy, oxidative stress, the gradual degradation of the organelles that power everything else. You've encountered four names being discussed — NAD+, MOTS-c, SS-31, Humanin — and you want to understand what each actually does, why they're being discussed together, and whether the combination logic holds up.7 min readGrowth hormone and recoveryMK-677 vs injectable GH secretagogues — the decision treeThe syringe sits on the bathroom counter at 9 PM. You've done the research. You've talked to a prescribing provider. You're starting a GH secretagogue protocol and the question that was easy to avoid in the abstract is now concrete: do you inject this, or is there a reason to consider the oral option instead? The mechanism overlaps. The goal is similar. The biology diverges in ways that matter, and the practical trade-offs are real enough that the choice deserves more than a convenience calculation.8 min readMitochondrial healthNAD+ vs NMN vs NR — the precursor conversationYou're standing in the supplement aisle — or the online equivalent of it, scrolling through a longevity stack that someone recommended on a podcast — and there are three things that look related: NAD+, NMN, and NR. They're all described as "NAD+ support." They're all priced somewhere between expensive and extremely expensive. They're all backed by citations to researchers whose names you half-recognize. And the differences between them are explained, in every product description you've read, in a way that somehow makes it less clear what you should actually be taking, not more.9 min readCompounding and complianceOral vs injectable peptide bioavailability — what the route actually changesYou found a peptide you're interested in and then you found what appears to be an oral version of it, and the oral version is cheaper and obviously more convenient and you'd rather not inject yourself if you can avoid it. Before you order the capsules, there's a question worth asking. Not a rhetorical question. A pharmacological one: does this compound actually survive the trip from your mouth to your bloodstream in any meaningful quantity?6 min readImmune modulationOral vs IV vs SubQ glutathione — what the evidence actually supportsYou've been reading about glutathione for a while now. The word shows up in detox conversations, anti-aging conversations, skin health conversations, chronic illness conversations, and functional medicine consultations. Everyone seems to agree it's important. What nobody seems to agree on is how to actually get it into your body — or whether most of the ways people try actually work. You're trying to decide between a daily oral supplement, periodic IV infusions, a subcutaneous injection protocol, or just ignoring the entire category and moving on. The decision deserves a cleaner framework than most of what's available.7 min readCompounding and complianceRoute comparison — subcutaneous vs intramuscular vs intravenous for peptidesThe compounding pharmacy ships the vials and includes no instructions about where to inject. You've watched three videos on YouTube, each of which says something slightly different, and you have a syringe in your hand and you're not confident you know what you're doing. The route question — subcutaneous or intramuscular — feels like a technical detail. It isn't. Route of administration changes the pharmacokinetics of a compound: how fast it enters the bloodstream, how high the peak concentration gets, how long it stays active, and sometimes whether it gets to the right place at all.9 min readCompounding and compliancePeptide stacks for longevity vs performance — different goals, different combinationsYou're 48. You train four days a week, you sleep reasonably well, your labs are broadly fine, and you've been reading about peptides for six months. You have a list of compounds and no coherent framework for how they fit together. Someone told you BPC-157 was good. Someone else said Epitalon was what you actually needed. A forum thread convinced you that Ipamorelin plus CJC-1295 was the move, but then another thread contradicted it with an argument about IGF-1 and cancer risk that you haven't been able to shake. The problem isn't information. You have too much information. The problem is a framework for understanding what you're actually trying to do.10 min readRecovery and inflammationPeptides vs stem cell therapy for joints and recoveryYour orthopedic surgeon looked at the MRI and said the damage is real, the cartilage isn't coming back on its own, and the options between doing nothing and doing surgery include a range of regenerative procedures he may or may not perform. You've seen advertisements for stem cell therapy clinics that use language like "your body's own healing power" and charge several thousand dollars for a single treatment. You've also heard about peptides — BPC-157 specifically, or TB-500 — that people use for the same categories of injury at a fraction of the cost. The question is not just which is more effective. The question is what the evidence actually says, what each of these things actually does, and what the difference is between a legitimate regenerative medicine approach and something that exceeds its evidence base in ways you should know about.10 min readHormonal and endocrinePeptides vs HRT/TRT — when each fits and how they integrateYour labs come back and the numbers are lower than they were five years ago. Not flagged out of range, or flagged at the edge of the reference interval, or clearly deficient — depending on which panel your provider ran. You feel different than you did. Sleep is worse, energy is lower, body composition has shifted despite the same habits, and you're having a conversation you didn't expect to be having in your forties about what to do about it. And then someone mentions peptides, and you're not sure whether that's an alternative to hormone replacement, an addition to it, or something in a completely different category.10 min readRecovery and inflammationPeptides vs PRP vs bone marrow aspirate concentrate — picking regenerative interventionsYour knee has been telling you something for six months. Or your Achilles. Or the rotator cuff that never quite finished healing from the incident three years ago. You've done physical therapy, you've been patient, the imaging shows something your orthopedist calls "degenerative changes" or "partial tearing" or "tendinosis," and now you're in a conversation about regenerative options. Three names keep appearing: PRP, BMAC, and peptides. You want to understand what each one actually is, what the evidence says, and how to think about which one — if any — makes sense for what you're dealing with.10 min readCompounding and complianceWhen to choose peptides vs traditional approaches — the meta-decision frameworkYou've been reading about peptides long enough that you've started wondering whether you're looking at a legitimate part of modern medicine or a sophisticated version of the supplement industry's tendency to package hope in molecular language. That skepticism is healthy. It's also incomplete. The honest answer is that peptides occupy a real but specifically bounded place in the clinical landscape, and the question isn't whether they belong there — they do — but when they're the right tool and when something else is.9 min readCompounding and compliancePeptides for prevention vs treatment — when each frame appliesYou've been reading about BPC-157 for three weeks. Your knee tendinopathy is real — it's been limiting your training for six months — but you've also found yourself three tabs deep into longevity stacks and wondering whether you should be taking something for your gut, your cognition, your aging generally. The original problem is concrete. The prevention rationale is vaguer. Somewhere in the research you noticed that the distinction between those two framings matters, and you're right that it does, but you haven't found anyone who explains why.10 min readRecovery and inflammationPeptides vs exosomes — what's different and what's similarYou've been told two different things by two different practitioners. One says peptides — specific molecules, specific mechanisms, compounds that have been studied long enough to have something to say about. The other says exosomes — nanovesicles carrying a rich cargo of cellular signals, a newer and more complex tool, something closer to the regenerative medicine that's been making headlines. Both practitioners sound confident. The price tags are very different. The question you're left with is what the difference actually is, what the evidence actually says, and how to think about which one makes sense for what you're dealing with.10 min readMetabolic healthPeptides vs fasting and fasting mimetics — overlapping or distinct?You're trying to build a metabolic optimization approach and you've arrived at a crossroads that nobody's mapped very clearly. On one side: fasting, in its various forms, with decades of research and a straightforward mechanistic story. On the other side: a collection of compounds — some pharmaceutical, some peptide, some nutritional — that appear to produce some of the same effects without requiring you to stop eating. The question isn't really which one is better. The question is what they're each doing, where they overlap, and how to think about the whole category before you decide what belongs in your life.9 min readCompounding and compliancePeptides vs FDA-approved medications — the honest comparisonYou're looking at two columns. One column has your medications — the things with insurance codes, the things your primary care provider prescribed, the things that come in branded packaging from a regulated pharmacy. The other column has peptides — the things with compelling mechanisms, the things the optimization world talks about, the things you're injecting from a small vial your compounding pharmacy mailed you. You want to know whether these two things belong in the same conversation, whether one can substitute for the other, and whether anyone in the medical establishment is going to tell you something honest about how the two compare.10 min readAnti-aging and cellular healthPeptides vs rapamycin for longevity — the decision frameworkYou're trying to decide where to start. You've read enough to know that the longevity pharmacology space has more than one lane, that something called rapamycin exists and appears in research conversations with unusual frequency, and that peptides occupy a different part of the landscape. What you haven't found is a direct comparison that treats both honestly — where the evidence is strong, where it's speculative, and how to think about the choice rather than just hand you a preference.9 min readCompounding and compliancePeptides vs supplements — when to escalate and when supplements are enoughYou've been taking supplements for years. Vitamin D, fish oil, magnesium, maybe a B-complex, possibly a few things you found in the back of a cabinet whose original purpose you've half-forgotten. You feel generally okay but not quite the way you want to feel, and the gap between okay and genuinely functional has started to seem like something worth addressing more deliberately. Someone mentions peptides. You pull up some information, the mechanisms sound compelling, the protocols look complex and clinical and you're not sure if you're ready for that, and you're also not sure if what you've been doing is actually covering the territory you think it's covering.10 min readCompounding and compliancePeptides vs supplements vs medications — the budget allocation questionYou have some amount of money you're willing to spend on your health, and you're trying to figure out where it goes. The options span an enormous range: a ten-dollar bottle of vitamin D from the pharmacy, a thirty-dollar creatine tub, a sixty-dollar monthly statin prescription, a two-hundred-dollar peptide protocol, a five-hundred-dollar concierge medicine membership, a thousand-dollar IV nutrient drip. The marketing across all of these is confident. The evidence behind all of these is not. Making a rational allocation decision requires a framework that most of this industry has no financial incentive to provide.10 min readSexual healthPT-141 vs PDE5 inhibitors (Viagra, Cialis) — different drug, different systemThe conversation at the pharmacy counter, or more often now on the app that ships pills in discrete packaging, usually goes like this: you want something for sexual function, the question is which one, and the answer comes in terms of timing and duration and whether you need it as-needed or daily. Four hours vs. thirty-six hours. Generic or brand. That's the decision tree as most people experience it.7 min readRecovery and inflammationBPC-157 vs TB-500 vs Thymosin Beta-4 vs ARA-290 — the regenerative peptide fieldYou hurt something and it's not getting better. Not dramatically — not torn-tendon surgery territory — but the kind of injury that sits at 60 percent for months, that flares when you push it, that has accumulated enough frustrating physiology-appointments and marginal improvements that you've started looking at the literature yourself. Or maybe it's the gut: a chronically inflamed GI tract that confounds every elimination diet and sits there as a low-grade interference in your life. You've heard that some peptides are researched specifically for tissue repair. You've encountered four names in particular — BPC-157, TB-500, Thymosin Beta-4, ARA-290 — and you want to understand what each actually does before you bring any of them into a clinical conversation.9 min readMetabolic healthSema vs Tirz vs Retatrutide — picking your incretinYou've been told there are options now. Your provider mentioned semaglutide, then mentioned tirzepatide, then someone in the waiting room mentioned something called retatrutide, and you left with three names written on your phone and no clear sense of which one is actually right for you. The differences are not cosmetic. The mechanism, the evidence base, the regulatory status, and the practical access path diverge in ways that matter — and chasing the highest weight-loss number from a clinical trial abstract is not the same as making the right decision for your specific situation.10 min readMetabolic healthSemaglutide vs. tirzepatide: how to actually decide between themYou've done enough research to know that both medications are weekly injectables, that both work through GLP-1, that both have produced results in trials that made headlines. And now you're at the actual decision point — which one, and why — and the information available online tends to either oversimplify it ("tirzepatide is stronger, tirzepatide wins") or hedge so thoroughly it says nothing useful. The honest answer is that it depends on specific things about you, and those things can be named.6 min readRecovery and inflammationTB-500 vs Thymosin Beta-4 — when a fragment isn't the whole moleculeYou ordered it from a research peptide supplier, the vial arrived, and you reconstituted it with bacteriostatic water the way the forum posts told you to. The label says TB-500. The studies you found online say Thymosin Beta-4. You've been assuming, reasonably enough, that these are the same thing — maybe the same thing with two names, the way ibuprofen and Advil are the same thing. They are not quite the same thing. The difference between them is worth understanding before you go any further, not because it invalidates the research, but because it changes what the research actually says about what you're holding.8 min readGrowth hormone and recoveryTesamorelin vs Sermorelin — when GHRH analogs aren't interchangeableThey're both GHRH analogs. They both work by binding to the growth hormone-releasing hormone receptor on pituitary somatotroph cells and prompting GH secretion. That shared mechanism makes them sound like two versions of the same thing — one perhaps newer, one perhaps stronger — and the choice between them a matter of price or availability or personal preference. That framing misses what actually distinguishes them, which matters enough to get right before a prescribing provider writes anything down.7 min readAnti-aging and cellular healthTopical vs injectable for skin peptides — what penetrates and what doesn'tThe serum costs eighty dollars. The ingredient list includes four peptides by name, each with its own clinical-sounding descriptor. The marketing copy mentions fibroblast activation and collagen synthesis and barrier restoration. You buy it, you use it for three months, and you're genuinely not sure whether anything happened or whether you've been lighting money on fire in elegant packaging. You want to know — specifically, mechanically — whether peptides in a bottle can actually do anything, or whether you're paying for the idea of peptides rather than their function.9 min read